ResearcherSaitama Medical UniversityNo recent work listed

Masahiko Komagome

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5039423598. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment. Co-author DOI 10.1016/j.asjsur.2023.03.162 ↗
[Strategy for Unresectable Pancreatic Cancer with Stenosis of the Duodenum - A Case Report]. Co-author PMID 28133089 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yoshifumi Beck · 2 shared papers, 2016–2023 · strength 0.26
- Paper Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment. DOI 10.1016/j.asjsur.2023.03.162 ↗
- Paper [Strategy for Unresectable Pancreatic Cancer with Stenosis of the Duodenum - A Case Report]. PMID 28133089 ↗
Riki Ninomiya · 2 shared papers, 2016–2023 · strength 0.26
- Paper Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment. DOI 10.1016/j.asjsur.2023.03.162 ↗
- Paper [Strategy for Unresectable Pancreatic Cancer with Stenosis of the Duodenum - A Case Report]. PMID 28133089 ↗
Ryota Kogure · 1 shared paper, 2023 · strength 0.19
- Paper Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment. DOI 10.1016/j.asjsur.2023.03.162 ↗
Satoru Abe · 1 shared paper, 2023 · strength 0.19
- Paper Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment. DOI 10.1016/j.asjsur.2023.03.162 ↗
Akifumi Kimura · 1 shared paper, 2023 · strength 0.19
- Paper Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment. DOI 10.1016/j.asjsur.2023.03.162 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.